Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lobaplatin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dialysis-based route ensures high purity lobaplatin anhydrous substance. Reduces steps and eliminates heavy metal residues for reliable supply chain.
Patent CN112225757A reveals a high-yield synthesis route for Lobaplatin Trihydrate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of diaminomethyl cyclobutane oxalate via patented dimerization and hydrogenation. Stable solid intermediate for Lobaplatin production ensuring supply continuity.
Patent CN103467528A details a streamlined Lobaplatin synthesis eliminating ion-exchange resins, offering cost reduction in pharmaceutical manufacturing and high-purity supply.
Patent CN102020679A reveals a superior oxalate-based synthesis for Lobaplatin Trihydrate, offering enhanced stability, higher yields, and streamlined purification for API manufacturing.
Advanced synthesis of diaminomethyl cyclobutane oxalate via FeCl3 catalysis ensures high-purity Lobaplatin intermediates with superior stability and scalable production capabilities.
Solve high-cost, hazardous synthesis of lobaplatin intermediate. New low-toxicity route improves yield by 30% with safer conditions. Scale to 100MT/yr.